Sotera Health Company (SHC)
Nasdaq: SHC · Services-Misc Health & Allied Services, NEC · Broadview Heights, OH · filing with the SEC since 2020
Grade5.6
◀ Past 6.3● Present 5.2▶ Future 5.4
Who owns Sotera Health Company
As filed with the SECHolders of 5% or more
5
Sessa Capital IM, L.P. holds 9.5% of Common Stock, par value $0.01 per share, as its SCHEDULE 13G/A filed Aug 14, 2026 says.
Directors and officers
38
report now, of 46 people on the record since 2020. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 5 named at left.
Holders of 5% or moreshare of the class, as filed
Sessa Capital IM, L.P.
SCHEDULE 13G/A · filed Aug 14, 2026 · Common Stock, par value $0.01 per share
Darsana Capital Partners LP
SCHEDULE 13G/A · filed Nov 14, 2025 · Common Stock, $0.01 par value per share
Sculptor Capital LP
SCHEDULE 13G/A · filed Aug 14, 2026 · Common Stock, par value $0.01 per share · 7.39% in Feb 13, 2026
Blackrock, Inc.
SCHEDULE 13G/A · filed Jul 30, 2026 · Common Stock · 6.2% in Jan 21, 2026
Sessa Capital GP, LLC
SCHEDULE 13G · filed Feb 17, 2026 · Common Stock, $0.01 par value per share
Sachem Head Capital Management LP
SCHEDULE 13G/A · filed Oct 9, 2026 · Common Stock, par value $0.01 per share · reported falling below 5%, from 5.46% in May 15, 2026
Warburg Pincus & Co.
SCHEDULE 13G/A · filed May 15, 2026 · Common Stock, par value $0.01 per share · reported falling below 5%, from 11.2% in Mar 10, 2026
Gtcr Investment Xi LLC
SCHEDULE 13G/A · filed May 15, 2026 · Common Stock, par value $0.01 per share · reported falling below 5%, from 11.2% in Mar 10, 2026
The Vanguard Group
SCHEDULE 13G/A · filed Mar 27, 2026 · Common Stock · reported falling below 5%, from 6.76% in Jan 30, 2026
What SHC reports owning in othersstakes of 5% or more, and other ties
40 subsidiaries in 14 countries, from the list filed with the 10-K filed Feb 24, 2026.
Insider tradesForm 4
18sales
0purchases
0sales on a scheduled plan
11people selling
$2.59Bsold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window11 of 46 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Warburg Pincus Partners II, L.P. | director | 2 | $511M | 0 | 0 | $0 |
| Warburg Pincus Partners Gp LLC | director | 2 | $388M | 0 | 0 | $0 |
| Gtcr Fund Xi/a LP | director | 2 | $294M | 0 | 0 | $0 |
| Warburg Pincus (Cayman) Xi, L.P. | director | 1 | $290M | 0 | 0 | $0 |
| Warburg Pincus Xi, L.P. | director | 1 | $290M | 0 | 0 | $0 |
| Warburg Pincus Private Equity Xi-C, L.P. | director | 1 | $282M | 0 | 0 | $0 |
| Gtcr Fund Xi/c LP | director | 1 | $193M | 0 | 0 | $0 |
| Warburg Pincus LLC | director | 1 | $159M | 0 | 0 | $0 |
| Gtcr Co-Invest Xi LP | director | 1 | $153M | 0 | 0 | $0 |
| Petras Michael B. Jr. | Executive Chairman | 5 | $33.5M | 0 | 0 | $0 |
| Rutz Michael P | President of Sterigenics | 1 | $2.8M | 0 | 0 | $0 |